Baena–Diez1 JM, et al. – This study assessed the cardiovascular risk ( 6–year coronary artery disease, stroke, cardiovascular disease incidence and overall mortality) in chronic immune–mediated diseases (rheumatoid arthritis, systemic lupus erythematosus or the following chronic immune–mediated inflammatory diagnoses groups: inflammatory bowel diseases, inflammatory polyarthropathies, systemic connective tissue disorders and spondylopathies); and estimated the population attributable fractions for all four end–points for each chronic immune–mediated inflammatory disease. The estimated cardiovascular risk and population impact were highest in systemic connective tissue disorders and rheumatoid arthritis, followed by inflammatory bowel diseases.